Before our partnership, Philips had limited in-house AB testing development capacity and lacked the resources to execute structured experimentation at scale across their complex global digital ecosystem. This meant they couldn't fully leverage insights from user behavior or systematically optimize their health technology platform. The absence of dedicated AB testing developers hindered their ability to make data-driven decisions, limited conversion growth, and left significant optimization opportunities untapped across their international markets.

Our partnership empowered Philips to consistently turn insights into action, driving measurable uplifts in conversion rates and digital performance year over year. Today, A/B testing is at the core of Philips' online strategy, enabling smarter decisions with proven business impact across their global health technology ecosystem.